Pharma channel feed

Fed­er­al ap­peals court over­turns $137M patent ver­dict against Roche — but the case is­n't closed just yet

4 years ago
Law

Am­gen re­ju­ve­nates En­brel ad cam­paign as biosim­i­lars re­main side­lined

4 years ago
Marketing

Phar­ma firms make new pledge to launch in all Eu­ro mar­kets at least 2 years post-au­tho­riza­tion

4 years ago

Bal­loon­ing 340B mar­ket reach­es al­most 15% of 2021 US phar­ma sales, IQVIA finds

4 years ago

Texas ju­ry awards Seagen near­ly $42M in En­her­tu patent case

4 years ago
Law

Hours af­ter Pfiz­er, Mod­er­na names its own new CFO with den­tal, health­care and au­to chops

4 years ago
People

Pfiz­er's Al­bert Bourla turns to an ac­com­plished deal­mak­er, strat­e­gy ex­pert for its next CFO

4 years ago

J&J takes Crohn's med Ste­lara in new di­rec­tion, with bold­er and brighter out­look

4 years ago
Marketing

BioN­Tech to ex­plore po­ten­tial of de­liv­er­ing mR­NA vac­cines oral­ly with new part­ner

4 years ago
Deals
R&D

How CMS in­de­pen­dence is at the fore­front of its Alzheimer's drug cov­er­age de­ci­sion

4 years ago
FDA+

AACR22: Am­gen re­veals new long-term da­ta for Lumakras, look­ing to keep press­ing mar­ket ad­van­tage over Mi­rati

4 years ago
R&D

Scoop: Ab­b­Vie drops IBS drug Viberzi in Cana­da, 'dev­as­tat­ing' pa­tients

4 years ago

An­oth­er lot of Mod­er­na's Rovi-made Spike­vax re­called af­ter par­tic­u­late found in vial

4 years ago
Coronavirus
Manufacturing

WP­P's VM­LY&R Health taps vet­er­an Gillis for CEO, amid re­fresh and first-ever health­care C-suite

4 years ago
Marketing

Lon­za­'s au­toma­tive man­u­fac­tur­ing tech ac­quired by Mil­li­pore­Sig­ma

4 years ago
Manufacturing

Vi­a­tris dou­bles down on Sesame Work­shop col­lab­o­ra­tion, kick­ing in an­oth­er $1M

4 years ago

As part of scheme to triple rev­enue this year, AGC adds on to Spain site for HPA­PIs

4 years ago
Manufacturing

As­traZeneca ad­vances net-ze­ro car­bon goals, adding Hon­ey­well deal and out­sider over­sight among new ESG ef­forts

4 years ago
Marketing

De­layed at the EMA, a gene ther­a­py play­er is grap­pling with a cash crunch

4 years ago
Cell/Gene Tx

Af­ter tak­ing a $73M hit, J&J part­ner Gen­mab los­es ar­bi­tra­tion over roy­al­ties on megablock­buster Darza­lex

4 years ago
Deals
Law

Enam­ine will re­sume op­er­a­tions on lim­it­ed ba­sis, CEO says, as Russ­ian forces with­draw from Ukrain­ian cap­i­tal

4 years ago

CMS fi­nal­izes re­stric­tions on Bio­gen's Alzheimer's drug cov­er­age, will on­ly fund use in clin­i­cal tri­als

4 years ago

When high costs mean un­filled pre­scrip­tions: New study digs in­to Medicare da­ta on se­niors skip­ping out

4 years ago

House, Sen­ate Dems in­tro­duce leg­is­la­tion to com­bat 'abu­sive' phar­ma busi­ness prac­tices

4 years ago
First page Previous page 209210211212213214215 Next page Last page
A service from the Financial Times